The Efficacy of Flupentixol-Melitracen in the Adjuvant Therapy of Ulcerative Colitis in the Chinese Population: A Meta-Analysis

<div>Flow diagram for selection of studies. 559 potentially relevant records identified and screened (PubMed: 164; Springer: 83; Elsevier ScienceDirect: 61; Google Scholar: 96; Wanfang Data: 68; CNKI:87); 51 potentially relevant records after duplicates or irrelevant records removed; 23 excluded based on the abstract (13 reviews; 10 not RCT); 28 retrieved for detailed assessment; 17 excluded based on review of the full text (10 only reported flupentixol-melitracen, but not for comparison; 7 due to nonavailable data); 11 separate studies included in meta-analysis.</div>

Gastroenterology Research and Practice

fig1

Figure 1

Figure 1: The Efficacy of Flupentixol-Melitracen in the Adjuvant Therapy of Ulcerative Colitis in the Chinese Population: A Meta-Analysis 